gene in people relapsing immediately after procedure With all the BCL2 antagonist venetoclax. 66 Resistance to those brokers has become connected to these mutations in all-around 70% of scenarios, Though they are often subclonal as well as their certain role resulting in resistance should be proven.??? "?????????????????????????????????????????????